All
- All
- Articles
- Calendar
- Compliance
- Newsletter
- Position Statements
- Press Release
- Regulatory
- Uncategorized
Homeopathy Consumers Are Online. Are You?
Online Marketing Techniques for Homeopathic Manufacturers Many of today’s consumers are looking for natural, safe, and effective drug products—and that means they’re turning to homeopathy....
3 Homeopathic Compliance Hot Spots to Watch
All drug products, homeopathic and allopathic alike, must be safe and effective. That means they have to be manufactured correctly, containing only the ingredients and...
How to Submit Monographs to the HPUS
FDA's Revised Draft Enforcement Document states the Agency considers only products that use substances monographed in the Homeopathic Pharmacopoeia of the United States (HPUS) as...
FDA Comment Period Extended: Help AAHP Present Manufacturers’ Voice
AAHP is preparing comments to “FDA Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry.” Initially published in December 2017, the...
AAHP’s Views on Aspects of FDA’s Revised Draft Guidance
Since 2015, the Food and Drug Administration (FDA) has been engaged in a reevaluation of Compliance Policy Guide 400.400, Conditions under Which Homeopathic Drugs May...
AAHP 2019: Reawakening the Regulatory and Retail Dialog
By Mark Land, AAHP President This year marks the fifth year in a cycle of regulatory review of homeopathic drug product labeling, safety, and quality....
Trump Nominates New FDA Commissioner
Senate Hearing Set for Nov. 20 By Pete Evich, AAHP Govt. Relations On Nov. 1, President Trump nominated Stephen Hahn, chief medical executive of...
